SCHEMBL6174534

SCHEMBL6174534

CCC(C1=C(O)CC2(CCCC2)OC1=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.39
HSD11B1 P28845 3/20 0.37
LMNA P02545 4/20 0.36
CHRM2 P08172 3/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
MLNR O43193 1/20 0.35
NR1I2 O75469 1/20 0.35
ABCB11 O95342 1/20 0.35
PGR P06401 1/20 0.35
CTSD P07339 1/20 0.35
ADRA2A P08913 1/20 0.35
PGA5 P0DJD9 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CTSE P14091 1/20 0.35
GABRA1 P14867 1/20 0.35
ADRA2C P18825 1/20 0.35
DRD1 P21728 1/20 0.35
HTR2A P28223 1/20 0.35
AGTR1 P30556 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176108 0.99 CYP2C9 (0.38) CYP2C9HSD11B1LMNACHRM2CHRM1
SCHEMBL6175954 0.90 HSD11B1 (0.48) CYP2C9HSD11B1CHRM2MLNRNR1I2
SCHEMBL6173671 0.88 HSD11B1 (0.52) CYP2C9HSD11B1
SCHEMBL6175182 0.87 ALDH1A1 (0.46) CYP2C9HSD11B1LMNACHRM2MLNR
SCHEMBL6174556 0.78 OPRD1 (0.44) CYP2C9CHRM2MLNRNR1I2ABCB11
SCHEMBL6174531 0.77 HSD11B1 (0.44) CYP2C9HSD11B1ALDH1A1TSHRL3MBTL1
SCHEMBL7489755 0.77 CYP2C9 (0.42) CYP2C9HSD11B1CHRM2CHRM1CHRM3
SCHEMBL6172876 0.77 KDM4E (0.35) LMNAPPARGALDH1A1MAPTCYP3A4
SCHEMBL6174513 0.77 KDM4E (0.35) LMNAPPARGALDH1A1MAPTCYP3A4
SCHEMBL6175172 0.75 LDHA (0.38) CYP2C9HSD11B1CHRM2MLNRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203770-B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases UPJOHN CO (US) 2005-03-09 EP claimed
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 EP claimed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP claimed
EP-0668860-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES PHARMACIA & UPJOHN COMPANY (US) 1995-08-30 EP claimed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 WO claimed
EP-1203770-B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases UPJOHN CO (US) 2005-03-09 EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP disclosed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 WO disclosed